Signal Bay Inc (OTCMKTS:SGBY) has confirmed that it is expanding into the Portland Oregon market in pursuit of new opportunities for growth. The announcement comes days after the provider of cannabis consulting operations and laboratory services announced it had exceeded the 700-business accounts milestone.

Signal Bay Expansion Drive

With the expansion into the Portland Oregon area, the company is hoping to exceed the 1000 mark on business accounts seen as a key driver or revenue going forward. Given that the company has vast experience in the cannabis industry, CEO, William Wardrop, expects a smooth sailing as the race to bolster market share heats up.

Signal Bay is relying on the support of another key player in the business to make its mark in the Portland area. Given the firm’s network of connections, the company remains confident of the expansion drive fueling further growth.

Expansion in Portland Oregon comes on the heels of the acquisition of Oregon Analytical Services LLC early in the year that expanded the company’s testing footprint into Eugene Oregon. Early in the year, the company also expanded its cannabis-testing footprint into the Emerald Triangle in Northern California.

Waldrop Robust Growth Sentiments

The chief executive remains bullish about the company’s growth prospects given the ongoing drive on the legalization of marijuana for medical use across the United States. Focus according to the executive shifts towards refining the production process in anticipation of a growth in demand for the firm’s cannabis testing facilities as more businesses come online.

Given Signal Bay Inc (OTCMKTS:SGBY) growing revenue base, Mr. Waldrop believes the stock is undervalued especially on ramping up business accounts. The executive has also quashed rumors that they are considering a reverse stock split in the near future. According to the executive, they may only increase the number of common or preferred shares in the market while putting the interest of current shareholders first.

Why Lotus Bio-Technology Development Corp (OTCMKTS:LBTD) Signed Deal With HC

Lotus Bio-Technology Development Corp (OTCMKTS:LBTD) confirmed about its joint development and marketing contract with ‘Hunan Cangshi Biological Technology Co. Limited’. The associate is a manufacturer, proprietor and developer of viable natural items that are manufactured using organic herbs. There is a special team in place to look after the cultivation process.

The President, Michael Palethorpe, reported that this contract is a major achievement for the company. It offers them a big opportunity to associate with a leading firm that has a similar goal and aligned values. Both companies intend to progress together in establishing viable, natural goods. HC is a choice subordinate with robust operations that will boost Lotus’s global sales strategy.

It products are not only organic and environment friendly, but they are also affordable and of premium quality. The finalized contract is projected to have a positive impact on next quarter sales.